Table 1.

Eleven Tx-expanded TCR clonotypes shared between PBMC and TIL in top 20 TCR clonotypes of post-PBMC or post-TIL

PXID	CDR3 region amino_acid	pre_TIL_Freq	pre_TIL_Rank	post_TIL_Freq	post_TIL_Rank	Ratio_TIL	pre_PBMC_Freq	pre_PBMC_Rank	post_PBMC_Freq	post_PBMC_Rank	Ratio_PBMC
6	CASSPPSRDYVSYEQYF	1.908%	3	2.263%	1	1.186	0.31%	8	0.409%	8	1.321
15	CASSHNVYTGELFF	0.03%	537	0.728%	5	24.571	0.807%	5	0.994%	5	1.233
16	CASTRTGYPAGPHNEQFF	1.033%	4	2.401%	3	2.324	2.432%	2	3.68%	2	1.513
16	CASSLSGGGEQYF	0.302%	12	0.913%	8	3.027	0.194%	16	0.362%	10	1.871
22	CASSEAETGGYEQYF	0.111%	125	1.395%	6	12.628	0.618%	4	0.952%	2	1.54
24	CASSSLRGPEDYGYTF	0.802%	1	3.142%	1	3.919	0.679%	2	1.222%	3	1.799
24	CASSSHYPTDTQYF	0.345%	11	1.29%	7	3.736	0.287%	6	0.52%	5	1.814
24	CAISDPRDSYEQYF	0.274%	13	0.825%	11	3.007	0.192%	11	0.224%	18	1.168
24	CASSDRGDPSEPQHF	0.55%	7	0.799%	12	1.452	2.832%	1	3.549%	1	1.253
24	CASSYSTSGQETQYF	0.154%	20	0.541%	17	3.507	0.184%	12	0.505%	6	2.736
27	CASSFHAGAGNTIYF	0.668%	5	1.306%	6	1.955	0.629%	5	0.967%	6	1.537

Patient ID indicates the patient who harbors a shared expanded top TCR clonotype.

Patient 6 and 15 are non-responders and patient 16, 22, 24, and 27 are responders (in red fonts).